Cary Street Partners Investment Advisory LLC Amgen Inc Transaction History

Cary Street Partners Investment Advisory LLC

$152 Billion
Q4 2024

A detailed history of Cary Street Partners Investment Advisory LLC transactions in Amgen Inc stock. As of the latest transaction made, Cary Street Partners Investment Advisory LLC holds 414 shares of AMGN stock, worth $113,303. This represents 0.07% of its overall portfolio holdings.

Number of Shares

414

Previous 12,249 96.62%

Holding current value

$113,303

Previous $3.95 Million 2634.54%

% of portfolio

0.07%

Previous 0.15%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$258.78 - $328.31 $3.06 Million - $3.89 Million	-11,835 Reduced 96.62%	414 $108 Million
Q3 2024 Oct 30, 2024	BUY	$309.38 - $337.38 $414,878 - $452,426	1,341 Added 12.29%	12,249 $3.95 Million
Q2 2024 Jul 22, 2024	BUY	$262.75 - $319.31 $393,599 - $478,326	1,498 Added 15.92%	10,908 $3.41 Million
Q1 2024 Apr 30, 2024	BUY	$268.87 - $324.56 $46,245 - $55,824	172 Added 1.86%	9,410 $2.68 Million
Q4 2023 Feb 07, 2024	BUY	$255.7 - $288.46 $2.06 Million - $2.32 Million	8,048 Added 676.3%	9,238 $2.66 Million
Q4 2023 Feb 05, 2024	SELL	$255.7 - $288.46 $1.91 Million - $2.15 Million	-7,464 Reduced 86.25%	1,190 $342,000
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $53,131 - $65,964	243 Added 2.89%	8,654 $2.33 Million
Q2 2023 Aug 10, 2023	SELL	$214.27 - $253.37 $3,214 - $3,800	-15 Reduced 0.18%	8,411 $1.87 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $55,995 - $68,249	248 Added 3.03%	8,426 $2.04 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $44,889 - $57,037	196 Added 2.46%	8,178 $2.15 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $503,688 - $568,068	2,244 Added 39.11%	7,982 $1.8 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $988,592 - $1.1 Million	4,285 Added 294.91%	5,738 $1.4 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $57,668 - $63,795	263 Added 22.1%	1,453 $351,000
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $16,308 - $18,663	-82 Reduced 6.45%	1,190 $268,000
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $3,184 - $3,730	-15 Reduced 1.17%	1,272 $270,000
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $5,839 - $6,478	25 Added 1.98%	1,287 $314,000
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $884,755 - $1.03 Million	-3,987 Reduced 75.96%	1,262 $314,000
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $1.05 Million - $1.25 Million	-4,858 Reduced 48.07%	5,249 $1.21 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $2.08 Million - $2.31 Million	8,848 Added 702.78%	10,107 $2.57 Million
Q2 2020 Aug 05, 2020	SELL	$197.81 - $242.74 $28,286 - $34,711	-143 Reduced 10.2%	1,259 $296,000
Q1 2020 Apr 21, 2020	SELL	$182.24 - $241.7 $38,088 - $50,515	-209 Reduced 12.97%	1,402 $284,000
Q4 2019 Feb 10, 2020	BUY	$189.21 - $243.2 $304,817 - $391,795	1,611 New	1,611 $388,000

Others Institutions Holding AMGN

# of Institutions

3,220

Shares Held

422M

Call Options Held

7.05M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.

Account

Cary Street Partners Investment Advisory LLC Amgen Inc Transaction History